Table 9.6b

Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006

Recipients with Liver Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
CyA Tac CyA+ MMF Tac+ MMF CyA+ Aza Tac+ Aza Siro+ MMF CyA+ Siro Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 395 9,438 1,128 13666 168 291 242 157 434 1,396 27315
% of All Regimens 1.4% 34.6% 4.1% 50.0% 0.6% 1.1% 0.9% 0.6% 1.6% 5.1% 100.0%
Induction Drug 0.3% 0.4% 0.7% 0.2% 0.0% 0.0% 0.0% 0.0% 0.7% 1.8% 0.4%
Atgam/NRATG/NRATS
OKT3 0.3% 0.6% 0.4% 1.2% 0.0% 0.7% 0.8% 0.0% 1.6% 1.6% 1.0%
Thymoglobulin 4.3% 7.8% 5.3% 6.0% 13.7% 10.7% 7.4% 1.3% 13.1% 19.2% 7.4%
Zenapax 5.3% 2.8% 8.3% 5.6% 0.6% 6.5% 8.7% 31.8% 3.0% 14.3% 5.3%
Simulect 8.6% 4.8% 20.3% 6.2% 1.8% 51.2% 12.4% 5.7% 6.0% 18.6% 7.5%
Campath 0.3% 2.2% 0.3% 0.7% 0.0% 0.0% 0.0% 0.0% 0.7% 1.7% 1.2%
No Induction Drugs Recorded 81.5% 82.0% 65.2% 81.4% 83.9% 30.9% 71.5% 61.1% 76.7% 78.4% 80.0%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.